Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies

Immuno-Oncology Technology(2023)10.1016/j.iotech.2023.100394Source: DataRank Database

Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies is a research paper published in Immuno-Oncology Technology (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.01)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Maria Rain Jennings ORCID,C. Lenahan ORCID,Matthew Manion ORCID,S. Courville,John Blazeck ORCID

Live enrichment

PubMed:37519414 PMC:PMC10374970 OpenAlex:https://openalex.org/W4382468066

National Institutes of Health

Grant: 1DP2CA280622-01

NCI NIH HHS

Grant: DP2 CA280622

National Institutes of Health

FWCI

1.01

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.esmoiotech.org/article/S2590018823000229/pdf

publisherhttp://www.esmoiotech.org/article/S2590018823000229/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2590018823000229?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2590018823000229?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.iotech.2023.100394

Fields of Study

Adenosine and Purinergic SignalingCAR-T cell therapy researchVirus-based gene therapy research

Keywords

Adenosine deaminaseExtracellularAdenosineJurkat cellsSecretionBiologyAdenosine A2B receptorGene isoformAdenosine kinaseBiochemistryCell biologyEnzymeAdenosine receptorImmune systemT cellReceptorImmunologyGeneProtein engineeringImmunotherapyT-cell TherapyCheckpoint Inhibition

Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies

FAIR Checklist

Authors (6)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)